CINCINNATI, Oct. 2, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that its wholly owned subsidiary Pilus Energy LLC ("Pilus Energy") was invited to participate at the EPA Technology Innovation Showcase ("the Showcase) on December 2, 2014 in Cincinnati, Ohio. The Showcase will be held at the EPA's Environmental Research Center and at the Kingsgate Marriott Conference Center (across the street from EPA) from 8:00 am to 5:00 pm on that day. Pilus Energy will present about its proprietary Electrogenic Bioreactor ("EBR") technology platform in the morning and then in the afternoon Pilus Energy's General Manager, Mr. Cody Harrison, will participate in a discussion panel.
The Link to the above mentioned EPA Showcase is as follows: (http://www.epa.gov/nrmrl/watercluster/docs/savethedate6j.pdf)
Tauriga would also like to announce that, in accordance with SEC Regulation Fair Disclosure ("Regulation FD"), it will occasionally use social media to disseminate certain information that may not merit an official Press Release. The main social media outlets that will be used by the Company are: the Tauriga Facebook page and the Pilus Energy Facebook and/or blog (links found below). Twitter will continue to be used for non-material information, or for information that is already public. The SEC is clear that this is a perfectly suitable method for communicating with investors as long as investors have been alerted about which social media will be used, and that the social media platforms do not have restricted access.
1) Tauriga's Facebook Page: (https://www.facebook.com/TaurigaSciencesInc)
2) Pilus Energy LLC Facebook Page: (https://www.facebook.com/PilusEnergyLLC)
3) Pilus Energy LLC Blog Page: (http://pilusenergy.wordpress.com/)
Regulation FD requires companies to distribute material information in a manner reasonably designed to get that information out to the public broadly and non-exclusively. It is intended to ensure that all investors have the ability to gain access to material information at the same time.
About Tauriga Sciences, Inc.:
Tauriga Sciences, Inc. (TAUG) is a diversified life sciences company focused on generating profitable revenues in the natural wellness sector and in developing a proprietary synthetic biology platform technology. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. Please visit the Company's corporate website at www.tauriga.com.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
CONTACT: Tauriga Sciences, Inc.: Dr. Stella M. Sung, Chairman and Chief Executive Officer Tauriga Sciences, Inc. www.tauriga.com San Diego: + 1-858-353-5749 Montreal: + 1-514-840-3697 Email: firstname.lastname@example.org
Source:Tauriga Sciences Inc